Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer
Cancers · 27.01.2023 · 15 (3) · 778
DOI: 10.3390/cancers15030778 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 27.01.2023. Verfasst von Harald Rosen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Sigmund Freud University, 1020 Vienna, Austria. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
A total of 60–80% of patients undergoing rectal resection (mostly as a treatment for rectal cancer) suffer from a variety of partly severe functional problems despite preservation of the anal sphincter. These patients are summarized under the term low anterior resection syndrome (LARS). Preoperative radiotherapy, vascular dissection and surgical excision of the low rectum and mesorectum lead, alone or all together, to a significant impairment of colonic and (neo-) rectal motility. This results in a variety of symptoms (multiple defecation episodes, recurrent episodes of urge, clustering, incontinence, etc.) which are associated with severe impairment of quality of life (QOL).
Methods
This narrative review summarizes the present state of knowledge regarding the pathophysiology of LARS as well as the evidence for the available treatment options to control the symptoms resulting from this condition.
Results
A review of the literature (Medline, Pubmed) reveals a variety of treatment options available to control symptoms of LARS. Medical therapy, with or without dietary modification, shows only a modest effect. Pelvic floor rehabilitation consisting of muscle exercise techniques as well as biofeedback training has been associated with improvement in LARS scores and incontinence, albeit with limited scientific evidence. Transanal irrigation (TAI) has gained interest as a treatment modality for patients with LARS due to an increasing number of promising data from recently published studies. Despite this promising observation, open questions about still-unclear issues of TAI remain under debate. Neuromodulation has been applied in LARS only in a few studies with small numbers of patients and partly conflicting results.
Conclusion
LARS is a frequent problem after sphincter-preserving rectal surgery and leads to a marked impairment of QOL. Due to the large number of patients suffering from this condition, mandatory identification, as well as treatment of affected patients, must be considered during surgical as well as oncological follow-up. The use of a standardized treatment algorithm will lead to sufficient control of symptoms and a high probability of a marked improvement in QOL.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgical Oncology, Sigmund Freud University, 1020 Vienna, Austria.
- Science Center Donaustadt, 1220 Vienna, Austria.
- Department of Oncology, University Clinic Donaustadt, 1220 Vienna, Austria.
ORCID-Profile: Christian Sebesta
Zitieren
APA
Rosen, H., Sebesta, C. G., & Sebesta, C. (2023). Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer. Cancers, 15(3), 778. https://doi.org/10.3390/cancers15030778
Vancouver
Rosen H, Sebesta CG, Sebesta C. Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer. Cancers. 2023;15(3):778. doi:10.3390/cancers15030778
BibTeX
@article{Rosen2023,
author = {Rosen, Harald and Sebesta, Christian G and Sebesta, Christian},
title = {Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer},
journal = {Cancers},
year = {2023},
volume = {15},
number = {3},
pages = {778},
doi = {10.3390/cancers15030778}
}
EUVIMED